Warehouse to wellness: Bob Mauch on modern pharmaceutical distribution - McKinsey & Company
Warehouse to Wellness: Bob Mauch on Modern Pharmaceutical Distribution
Cencora President and CEO Bob Mauch shares insights into the company’s innovations that enhance pharmaceutical distribution, ultimately improving patient outcomes. As a former pharmacist, Mauch emphasizes the vital role of distributors in delivering medications efficiently to patients, especially in response to new healthcare challenges.
With the rise of complex biologic therapies and evolving demands in healthcare, Cencora is leveraging advanced technologies such as AI, machine learning, and automation. For instance, the implementation of AI in inventory management allows the company to utilize predictive analytics. This capability helps determine the most efficient routes for products entering the network, ensuring timely access to medications—sometimes within just one or two days. Such improvements not only enhance service levels but directly contribute to better patient outcomes.
Additionally, Cencora has expanded its cold-chain logistics, essential for transporting sensitive cell and gene therapies. They conduct over 12,000 cryogenic shipments annually, relying on technology to monitor conditions, thereby assuring the integrity of the products.
Mauch highlights that integrating these digital capabilities is an ongoing journey, essential for managing complexity in healthcare. Looking forward, he aims for Cencora to remain a purpose-driven organization that harnesses AI and analytics, ensuring its position as a leader in the specialty market for advanced therapies. His vision reflects a commitment to continuous improvement, emphasizing patient access and the importance of delivering medications reliably and efficiently, ultimately fostering healthier futures in healthcare.


